Trial Profile
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ethosuximide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms EDONOT
- 09 May 2017 Status changed from recruiting to completed.
- 23 May 2014 New trial record